Skip to content

AcrySof™ IQ Vivity™ DFT015 (REF DFT015.125)Recalls & reported problems

Alcon Laboratories, Inc. · Sterile UV and Blue Light Filtering Acrylic Foldable Aspheric Wavefront-Shaping Posterior Chamber Intraocular Lens · Class 3 · Implant

Data updated Oct 13, 2026 from official FDA records · Editorial policy

Adverse event reports
3
Deaths reported
0
Injuries reported
3
Recalls naming it
0

Summary

The FDA's MAUDE database contains 3 adverse event reports that list this exact device (DI 00380652421089), received between Aug 10, 2022 and Aug 21, 2024 — classified as 3 injuries.

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. How this data works · Data updated Oct 13, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 1 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520261
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Adverse Event Without Identified Device or Use Problem3

Patient problems

  • Blurred Vision2
  • Corneal Edema1
  • Halo1
  • Retinal Tear1
  • Visual Disturbances1
  • Visual Impairment1

Recent adverse event reports

The 3 most recent of 3 reports, in the reporter's own words as published by the FDA.

  • InjuryAug 21, 2024Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    A GOVERNMENT AGENCY REPORTED THAT A PATIENT UNDERWENT CATARACT SURGERY ON THE RIGHT EYE. THE PROCEDURE WAS PERFORMED UNDER REGIONAL ANESTHESIA. DURING SEDATION, REGURGITATION OCCURRED, CAUSING COUGHING. AFTER EXAMINATION, DESATURATION, A CHEST X-RAY WAS REQUESTED PRIOR TO SURGERY. THE RESULTS SHOWED NO PULMONARY FOCUS. PATIENT SEEN AGAIN AT NEXT DAY OF SURGERY, POSTOPERATIVE EXAMINATION WAS NORMAL. THE PATIENT WAS SEEN AGAIN AFTER ONE WEEK OF THE SURGERY, PRIOR TO SURGERY ON THE LEFT EYE, THE SURGEON NOTED THAT THE VISUAL ACUITY OF THE PATIENT'S RIGHT EYE WAS 1/20, AND THE REST OF THE CLINICAL EXAMINATION WAS NORMAL. THE PATIENT WAS IMMEDIATELY REFERRED TO A RETINAL SURGEON FOR ADVICE. THE DIAGNOSIS OF INTRA-RETINAL SCHISIS WAS THEN EVOKED. AN ANGIOGRAPHIC EXAMINATION WAS CARRIED OUT ON AND FOUND NO RETINAL PERFUSION ANOMALY. IN VIEW OF THE LACK OF IMPROVEMENT IN VISUAL ACUITY, IT WAS DECIDED TO CARRY OUT A CEREBRO-ORBITAL MRI AND HYPERBARIC OXYGEN THERAPY. PATIENT'S CURRENT CONDITION IS UNCHANGED.

    Patient problems: Blurred Vision; Retinal Tear

    MAUDE report 20016681 ↗
  • InjuryApr 16, 2023Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    A NURSE REPORTED FOLLOWING THE INTRAOCULAR LENS IMPLANTATION THE PATIENT HAD EXPERIENCED BLURRY VISION AND POSITIVE DYSPHOTOPSIA. THE LENS WAS THEN EXPLANTED IN A SECONDARY PROCEDURE AND REPLACED WITH A MONOFOCAL LENS. ADDITIONAL INFORMATION HAS BEEN REQUESTED AND RECEIVED STATING THE PATIENT STILL HAD SYMPTOMS AT ONE WEEK POST OPERATIVE. IT COULD BE DUE TO GLAUCOMA DAMAGE.

    Patient problems: Halo; Visual Disturbances

    MAUDE report 16748638 ↗
  • InjuryAug 10, 2022Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    A PHYSICIAN REPORTED THAT, FOLLOWING INTRAOCULAR LENS (IOL) IMPLANT PROCEDURE, THE PATIENT WAS HAVING INSUFFICIENT ACUITY AT NEAR. THE LENS WAS EXCHANGED IN A SECONDARY PROCEDURE. ADDITIONAL INFORMATION WAS REQUESTED.

    Patient problems: Blurred Vision; Corneal Edema; Visual Impairment

    MAUDE report 15202571 ↗

Other Extended depth of focus intraocular lens devices

All Extended depth of focus intraocular lens devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page